SanaCurrents on Scholar Rock’s (SRRK) improving treatment for spinal muscular atrophy (SMA)
Scholar Rock Holding Corporatio (NASDAQ:SRRK) Probability Sentiment SUMMARY Spinal muscular atrophy (SMA) is a genetic [...]
Scholar Rock Holding Corporatio (NASDAQ:SRRK) Probability Sentiment SUMMARY Spinal muscular atrophy (SMA) is a genetic [...]
Wave Life Sciences Ltd. (NASDAQ:WVE) Probability Sentiment SUMMARY Approval of Amylyx Pharmaceuticals, Inc.’s (NASDAQ:AMLX) Relyvrio [...]
Springworks Therapeutics, Inc. (NASDAQ:SWTX) Probability Sentiment SUMMARY Desmoid tumors attack the body’s soft tissues, usually [...]
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Probability Sentiment SUMMARY The FDA informed Akebia Therapeutics, Inc. (NASDAQ:AKBA) on [...]
Equillium, Inc. (NASDAQ:EQ) Probability Sentiment SUMMARY Six-year-old Equillium, Inc.’s (NASDAQ:EQ) lead drug, itolizumab, is in [...]
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Probability Sentiment SUMMARY The pipeline at Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) targets [...]
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Probability Sentiment SUMMARY Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is advancing the small [...]
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Probability Sentiment SUMMARY X4 Pharmaceuticals, Inc.’s (NASDAQ:XFOR) mavorixafor posted impressive clinical [...]